Loading…

Detection of tumour DNA in serum of colorectal cancer patients

Circulating tumour DNA has previously been detected in serum and plasma of patients with lung cancer and head and neck cancer. These observations could potentially lead to new, specific and non-invasive tools for diagnosis, prognosis and follow-up in neoplastic disease, if found to be a more general...

Full description

Saved in:
Bibliographic Details
Published in:Scandinavian journal of clinical and laboratory investigation 1997, Vol.57 (7), p.601-604
Main Authors: De Kok, J. B., Van Solinge, W. W., Ruers, T. J. M., Roelofs, R. W. H. M., Van Muijen, G. N. P., Willems, J. L., Swinkels, D. W.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c430t-8a5dc36a1f870408ef08518f9acf8c6f483dfc6ca7e25de5c09f4e62374e612a3
cites cdi_FETCH-LOGICAL-c430t-8a5dc36a1f870408ef08518f9acf8c6f483dfc6ca7e25de5c09f4e62374e612a3
container_end_page 604
container_issue 7
container_start_page 601
container_title Scandinavian journal of clinical and laboratory investigation
container_volume 57
creator De Kok, J. B.
Van Solinge, W. W.
Ruers, T. J. M.
Roelofs, R. W. H. M.
Van Muijen, G. N. P.
Willems, J. L.
Swinkels, D. W.
description Circulating tumour DNA has previously been detected in serum and plasma of patients with lung cancer and head and neck cancer. These observations could potentially lead to new, specific and non-invasive tools for diagnosis, prognosis and follow-up in neoplastic disease, if found to be a more general phenomenon. To test if tumour DNA is also present in serum of patients with colorectal cancer, we selected 14 colorectal cancer patients with advanced disease. In seven patients. K-ras mutations were detected in the primary tumour, using mutant-specific primers for point mutations in codon 12 or 13 of the K-ras gene. All patients were analysed for mutant DNA in serum. Tumour-specific point mutations, corresponding to the K-ras mutations found in the primary tumour were detected in the serum of all patients but one. No mutant K-ras could be detected in the serum of seven patients without K-ras mutations in the primary tumour. These results may be useful in assessing tumour burden in patients with neoplastic disease. Moreover, consecutive testing of serum tumour DNA after surgery or chemotherapy may be used as a tumour marker for recurrent disease.
doi_str_mv 10.3109/00365519709055283
format article
fullrecord <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_2089775</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79454907</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-8a5dc36a1f870408ef08518f9acf8c6f483dfc6ca7e25de5c09f4e62374e612a3</originalsourceid><addsrcrecordid>eNp9kU1LxDAQhoMouq7-AA9CD-KtmjRNk6AIy_oJohc9lzGdYKVt1iRF_Pdm2VUQwUtCMs87TJ4QcsDoCWdUn1LKKyGYllRTIQrFN8iECVrkslLVJpks63kC-A7ZDeGNpjNX5TbZ1lzLUrMJubjEiCa2bsiczeLYu9Fnlw-zrB2ygH7sl9fGdc4nCrrMwGDQZwuILQ4x7JEtC13A_fU-Jc_XV0_z2_z-8eZuPrvPTclpzBWIxvAKmFWSllShpUowZTUYq0xlS8UbayoDEgvRoDBU2xKrgsu0sgL4lByv-i68ex8xxLpvg8GugwHdGGqpS1FqKhPIVqDxLgSPtl74tgf_WTNaL53Vf5ylzOG6-fjSY_OTWEtK9aN1HYKBzvrkoA0_WEGVllIk7HyFtYN1vocP57umjvCZ5H1n-H9TnP2KvyJ08dWAx_otfcqQ9P7zhi9n3ZgQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79454907</pqid></control><display><type>article</type><title>Detection of tumour DNA in serum of colorectal cancer patients</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>De Kok, J. B. ; Van Solinge, W. W. ; Ruers, T. J. M. ; Roelofs, R. W. H. M. ; Van Muijen, G. N. P. ; Willems, J. L. ; Swinkels, D. W.</creator><creatorcontrib>De Kok, J. B. ; Van Solinge, W. W. ; Ruers, T. J. M. ; Roelofs, R. W. H. M. ; Van Muijen, G. N. P. ; Willems, J. L. ; Swinkels, D. W.</creatorcontrib><description>Circulating tumour DNA has previously been detected in serum and plasma of patients with lung cancer and head and neck cancer. These observations could potentially lead to new, specific and non-invasive tools for diagnosis, prognosis and follow-up in neoplastic disease, if found to be a more general phenomenon. To test if tumour DNA is also present in serum of patients with colorectal cancer, we selected 14 colorectal cancer patients with advanced disease. In seven patients. K-ras mutations were detected in the primary tumour, using mutant-specific primers for point mutations in codon 12 or 13 of the K-ras gene. All patients were analysed for mutant DNA in serum. Tumour-specific point mutations, corresponding to the K-ras mutations found in the primary tumour were detected in the serum of all patients but one. No mutant K-ras could be detected in the serum of seven patients without K-ras mutations in the primary tumour. These results may be useful in assessing tumour burden in patients with neoplastic disease. Moreover, consecutive testing of serum tumour DNA after surgery or chemotherapy may be used as a tumour marker for recurrent disease.</description><identifier>ISSN: 0036-5513</identifier><identifier>EISSN: 1502-7686</identifier><identifier>DOI: 10.3109/00365519709055283</identifier><identifier>PMID: 9397491</identifier><identifier>CODEN: SJCLAY</identifier><language>eng</language><publisher>Oslo: Informa UK Ltd</publisher><subject>Biological and medical sciences ; circulating DNA ; Colorectal Neoplasms - diagnosis ; Colorectal Neoplasms - genetics ; Colorectal Neoplasms - prevention &amp; control ; DNA Mutational Analysis ; DNA, Neoplasm - analysis ; Gastroenterology. Liver. Pancreas. Abdomen ; Genes, ras - genetics ; Humans ; K-ras ; Mass Screening ; Medical sciences ; mutation screening ; Other diseases. Semiology ; Point Mutation ; Polymerase Chain Reaction ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><ispartof>Scandinavian journal of clinical and laboratory investigation, 1997, Vol.57 (7), p.601-604</ispartof><rights>1997 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1997</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-8a5dc36a1f870408ef08518f9acf8c6f483dfc6ca7e25de5c09f4e62374e612a3</citedby><cites>FETCH-LOGICAL-c430t-8a5dc36a1f870408ef08518f9acf8c6f483dfc6ca7e25de5c09f4e62374e612a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2089775$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9397491$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>De Kok, J. B.</creatorcontrib><creatorcontrib>Van Solinge, W. W.</creatorcontrib><creatorcontrib>Ruers, T. J. M.</creatorcontrib><creatorcontrib>Roelofs, R. W. H. M.</creatorcontrib><creatorcontrib>Van Muijen, G. N. P.</creatorcontrib><creatorcontrib>Willems, J. L.</creatorcontrib><creatorcontrib>Swinkels, D. W.</creatorcontrib><title>Detection of tumour DNA in serum of colorectal cancer patients</title><title>Scandinavian journal of clinical and laboratory investigation</title><addtitle>Scand J Clin Lab Invest</addtitle><description>Circulating tumour DNA has previously been detected in serum and plasma of patients with lung cancer and head and neck cancer. These observations could potentially lead to new, specific and non-invasive tools for diagnosis, prognosis and follow-up in neoplastic disease, if found to be a more general phenomenon. To test if tumour DNA is also present in serum of patients with colorectal cancer, we selected 14 colorectal cancer patients with advanced disease. In seven patients. K-ras mutations were detected in the primary tumour, using mutant-specific primers for point mutations in codon 12 or 13 of the K-ras gene. All patients were analysed for mutant DNA in serum. Tumour-specific point mutations, corresponding to the K-ras mutations found in the primary tumour were detected in the serum of all patients but one. No mutant K-ras could be detected in the serum of seven patients without K-ras mutations in the primary tumour. These results may be useful in assessing tumour burden in patients with neoplastic disease. Moreover, consecutive testing of serum tumour DNA after surgery or chemotherapy may be used as a tumour marker for recurrent disease.</description><subject>Biological and medical sciences</subject><subject>circulating DNA</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Colorectal Neoplasms - genetics</subject><subject>Colorectal Neoplasms - prevention &amp; control</subject><subject>DNA Mutational Analysis</subject><subject>DNA, Neoplasm - analysis</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Genes, ras - genetics</subject><subject>Humans</subject><subject>K-ras</subject><subject>Mass Screening</subject><subject>Medical sciences</subject><subject>mutation screening</subject><subject>Other diseases. Semiology</subject><subject>Point Mutation</subject><subject>Polymerase Chain Reaction</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><issn>0036-5513</issn><issn>1502-7686</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNp9kU1LxDAQhoMouq7-AA9CD-KtmjRNk6AIy_oJohc9lzGdYKVt1iRF_Pdm2VUQwUtCMs87TJ4QcsDoCWdUn1LKKyGYllRTIQrFN8iECVrkslLVJpks63kC-A7ZDeGNpjNX5TbZ1lzLUrMJubjEiCa2bsiczeLYu9Fnlw-zrB2ygH7sl9fGdc4nCrrMwGDQZwuILQ4x7JEtC13A_fU-Jc_XV0_z2_z-8eZuPrvPTclpzBWIxvAKmFWSllShpUowZTUYq0xlS8UbayoDEgvRoDBU2xKrgsu0sgL4lByv-i68ex8xxLpvg8GugwHdGGqpS1FqKhPIVqDxLgSPtl74tgf_WTNaL53Vf5ylzOG6-fjSY_OTWEtK9aN1HYKBzvrkoA0_WEGVllIk7HyFtYN1vocP57umjvCZ5H1n-H9TnP2KvyJ08dWAx_otfcqQ9P7zhi9n3ZgQ</recordid><startdate>1997</startdate><enddate>1997</enddate><creator>De Kok, J. B.</creator><creator>Van Solinge, W. W.</creator><creator>Ruers, T. J. M.</creator><creator>Roelofs, R. W. H. M.</creator><creator>Van Muijen, G. N. P.</creator><creator>Willems, J. L.</creator><creator>Swinkels, D. W.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Scandinavian University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1997</creationdate><title>Detection of tumour DNA in serum of colorectal cancer patients</title><author>De Kok, J. B. ; Van Solinge, W. W. ; Ruers, T. J. M. ; Roelofs, R. W. H. M. ; Van Muijen, G. N. P. ; Willems, J. L. ; Swinkels, D. W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-8a5dc36a1f870408ef08518f9acf8c6f483dfc6ca7e25de5c09f4e62374e612a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Biological and medical sciences</topic><topic>circulating DNA</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Colorectal Neoplasms - genetics</topic><topic>Colorectal Neoplasms - prevention &amp; control</topic><topic>DNA Mutational Analysis</topic><topic>DNA, Neoplasm - analysis</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Genes, ras - genetics</topic><topic>Humans</topic><topic>K-ras</topic><topic>Mass Screening</topic><topic>Medical sciences</topic><topic>mutation screening</topic><topic>Other diseases. Semiology</topic><topic>Point Mutation</topic><topic>Polymerase Chain Reaction</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De Kok, J. B.</creatorcontrib><creatorcontrib>Van Solinge, W. W.</creatorcontrib><creatorcontrib>Ruers, T. J. M.</creatorcontrib><creatorcontrib>Roelofs, R. W. H. M.</creatorcontrib><creatorcontrib>Van Muijen, G. N. P.</creatorcontrib><creatorcontrib>Willems, J. L.</creatorcontrib><creatorcontrib>Swinkels, D. W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Scandinavian journal of clinical and laboratory investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De Kok, J. B.</au><au>Van Solinge, W. W.</au><au>Ruers, T. J. M.</au><au>Roelofs, R. W. H. M.</au><au>Van Muijen, G. N. P.</au><au>Willems, J. L.</au><au>Swinkels, D. W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Detection of tumour DNA in serum of colorectal cancer patients</atitle><jtitle>Scandinavian journal of clinical and laboratory investigation</jtitle><addtitle>Scand J Clin Lab Invest</addtitle><date>1997</date><risdate>1997</risdate><volume>57</volume><issue>7</issue><spage>601</spage><epage>604</epage><pages>601-604</pages><issn>0036-5513</issn><eissn>1502-7686</eissn><coden>SJCLAY</coden><abstract>Circulating tumour DNA has previously been detected in serum and plasma of patients with lung cancer and head and neck cancer. These observations could potentially lead to new, specific and non-invasive tools for diagnosis, prognosis and follow-up in neoplastic disease, if found to be a more general phenomenon. To test if tumour DNA is also present in serum of patients with colorectal cancer, we selected 14 colorectal cancer patients with advanced disease. In seven patients. K-ras mutations were detected in the primary tumour, using mutant-specific primers for point mutations in codon 12 or 13 of the K-ras gene. All patients were analysed for mutant DNA in serum. Tumour-specific point mutations, corresponding to the K-ras mutations found in the primary tumour were detected in the serum of all patients but one. No mutant K-ras could be detected in the serum of seven patients without K-ras mutations in the primary tumour. These results may be useful in assessing tumour burden in patients with neoplastic disease. Moreover, consecutive testing of serum tumour DNA after surgery or chemotherapy may be used as a tumour marker for recurrent disease.</abstract><cop>Oslo</cop><pub>Informa UK Ltd</pub><pmid>9397491</pmid><doi>10.3109/00365519709055283</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0036-5513
ispartof Scandinavian journal of clinical and laboratory investigation, 1997, Vol.57 (7), p.601-604
issn 0036-5513
1502-7686
language eng
recordid cdi_pascalfrancis_primary_2089775
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Biological and medical sciences
circulating DNA
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - genetics
Colorectal Neoplasms - prevention & control
DNA Mutational Analysis
DNA, Neoplasm - analysis
Gastroenterology. Liver. Pancreas. Abdomen
Genes, ras - genetics
Humans
K-ras
Mass Screening
Medical sciences
mutation screening
Other diseases. Semiology
Point Mutation
Polymerase Chain Reaction
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
title Detection of tumour DNA in serum of colorectal cancer patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T21%3A06%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Detection%20of%20tumour%20DNA%20in%20serum%20of%20colorectal%20cancer%20patients&rft.jtitle=Scandinavian%20journal%20of%20clinical%20and%20laboratory%20investigation&rft.au=De%20Kok,%20J.%20B.&rft.date=1997&rft.volume=57&rft.issue=7&rft.spage=601&rft.epage=604&rft.pages=601-604&rft.issn=0036-5513&rft.eissn=1502-7686&rft.coden=SJCLAY&rft_id=info:doi/10.3109/00365519709055283&rft_dat=%3Cproquest_pasca%3E79454907%3C/proquest_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-8a5dc36a1f870408ef08518f9acf8c6f483dfc6ca7e25de5c09f4e62374e612a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79454907&rft_id=info:pmid/9397491&rfr_iscdi=true